NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies-Reference-Cited by-同舟云学术

NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies

Published:2009-03-27 Issue:5 Volume:11 Page:343-355
ISSN:1536-1632
Container-title:Molecular Imaging and Biology
language:en
Short-container-title:Mol Imaging Biol

Author:

Spence Alexander M.,Muzi Mark,Link Jeanne M.,O’Sullivan Finbarr,Eary Janet F.,Hoffman John M.,Shankar Lalitha K.,Krohn Kenneth A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11307-009-0215-2.pdf

Reference57 articles.

1. Grierson JR, Schwartz JL, Muzi M, Jordan R, Krohn KA (2004) Metabolism of 3′-deoxy-3′-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. Nucl Med Biol 31:829–837

2. Brandes AA, Tosoni A, Spagnolli F et al (2008) Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro Oncol 10:361–367

3. Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE (2007) Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82:81–83

4. Spence AM, Muzi M, Link JM, Hoffman JM, Eary JF, Krohn KA (2008) NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies. Mol Imaging Biol 10:271–280

5. Muzi M, Spence AM, O'Sullivan F et al (2006) Kinetic analysis of 3′-deoxy-3′-18F-fluorothymidine in patients with gliomas. J Nucl Med 47:1612–1621

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron emission tomography and perfusion weighted imaging in the detection of brain tumors recurrence;Neurosciences;2022-07

2. Joint application of biochemical markers and imaging techniques in the accurate and early detection of glioblastoma;Pathology - Research and Practice;2021-08

3. Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 – Radiological features and metric markers;Critical Reviews in Oncology/Hematology;2021-03

4. Central Nervous System Molecular Imaging;Molecular Imaging;2021

5. Imaging for Response Assessment in Cancer Clinical Trials;Seminars in Nuclear Medicine;2020-11